Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.

Cerebrospinal fluid concentrations of the norepinephrine metabolite, 3-methoxy-4-hydroxyphenylglycol (MHPG), the serotonin metabolite, 5-hydroxyindoleacetic acid (5-HIAA), and the dopamine metabolite, homovanillic acid, were measured in depressed patients before and after treatment with three putatively specific antidepressants. The expected specificity of action on these three neurotransmitter metabolites was not observed. Desipramine hydrochloride, a norepinephrine uptake inhibitor, reduced 5-HIAA as well as MHPG concentrations; zimeldine hydrochloride, a serotonin uptake inhibitor, reduced MHPG as well as 5-HIAA concentrations; and clorgyline, a selective monoamine oxidase type A inhibitor, which might be predicted to most affect 5-HIAA, dramatically reduced MHPG, moderately reduced homovanillic acid, and only modestly reduced 5-HIAA concentrations.

[1]  E. Robins,et al.  Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs. , 1984, The American journal of psychiatry.

[2]  H. Calil,et al.  The effect of desmethylimipramine on the metabolism of norepinephrine. , 1984, Life sciences.

[3]  M. Scheinin,et al.  Liquid chromatographic assay for CSF catecholamines using electrochemical detection. , 1984, Acta pharmacologica et toxicologica.

[4]  J. Bartko,et al.  Five antidepressant treatments in depressed patients. Effects on urinary serotonin and 5-hydroxyindoleacetic acid output. , 1984, Archives of general psychiatry.

[5]  R. Wyatt,et al.  Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments. , 1984, European journal of pharmacology.

[6]  M. Scheinin,et al.  Reduction of norepinephrine turnover by serotonergic drug in man. , 1984, Biological psychiatry.

[7]  W. Potter,et al.  Effects of antidepressant treatments on dopamine turnover in depressed patients. , 1983, Archives of general psychiatry.

[8]  M. Scheinin,et al.  Simultaneous determination of 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in cerebrospinal fluid with high-performance liquid chromatography using electrochemical detection. , 1983, Analytical biochemistry.

[9]  H. Calil,et al.  Effects of desmethylimipramine on plasma norepinephrine, pulse, and blood pressure , 1983, Clinical pharmacology and therapeutics.

[10]  J. Javaid,et al.  4 – Effects of Pharmacological Agents on MHPG , 1983 .

[11]  M. F. Sugrue,et al.  Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning. , 1983, Pharmacology & therapeutics.

[12]  A. Janowsky,et al.  Role of serotonergic input in the regulation of the beta-adrenergic receptor-coupled adenylate cyclase system. , 1982, Science.

[13]  H. Calil,et al.  Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients. , 1982, Archives of general psychiatry.

[14]  A. Åberg-Wistedt,et al.  A double–blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression , 1982, Acta psychiatrica Scandinavica.

[15]  S. Ross,et al.  A double‐blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression , 1982, Acta psychiatrica Scandinavica.

[16]  P. Cowen,et al.  β‐ADRENOCEPTOR AGONISTS ENHANCE 5‐HYDROXYTRYPTAMINE‐MEDIATED BEHAVIOURAL RESPONSES , 1982, British journal of pharmacology.

[17]  D. Murphy,et al.  Clorgyline. A new treatment for patients with refractory rapid-cycling disorder. , 1982, Archives of general psychiatry.

[18]  E. Robins,et al.  Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment , 1982, Psychological Medicine.

[19]  E. Costa,et al.  Typical and atypical antidepressants. Molecular mechanisms. , 1982, Advances in biochemical psychopharmacology.

[20]  R. Roth,et al.  Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment. , 1981, Archives of general psychiatry.

[21]  V. Sethy,et al.  Effect of norepinephrine uptake blocker on beta-adrenergic receptors of the rat cerebral cortex. , 1981, European journal of pharmacology.

[22]  D. Charney,et al.  Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. , 1981, Archives of general psychiatry.

[23]  F. Goodwin,et al.  Specific norepinephrine and serotonin uptake inhibitors in man: A crossover study with pharmacokinetic, biochemical, neuroendocrine and behavioral parameters , 1981, Acta psychiatrica Scandinavica. Supplementum.

[24]  K. Davis,et al.  Subtypes of depression based on excretion of MHPG and response to nortriptyline. , 1980, Archives of general psychiatry.

[25]  A. Schatzberg,et al.  MHPG as a predictor of antidepressant response to imipramine and maprotiline. , 1980, The American journal of psychiatry.

[26]  J. Stewart,et al.  Efficacy of desmethylimipramine in endogenomorphically depressed patients. , 1980, Psychopharmacology bulletin.

[27]  S. Potkin,et al.  Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls. , 1980, Psychopharmacology bulletin.

[28]  M. Åsberg,et al.  Plasma levels of chlorimipramine and its demethyl metabolite during treatment of depression , 1979, Clinical pharmacology and therapeutics.

[29]  D. Murphy,et al.  Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid , 1979, Journal of neurochemistry.

[30]  D. Murphy.  Substrate-selective monoamine oxidases--inhibitor, tissue, species and functional differences. , 1978, Biochemical pharmacology.

[31]  L. S. Kung,et al.  Development of β-adrenergic receptor subsensitivity by antidepressants , 1977, Nature.

[32]  F. Goodwin,et al.  Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects. , 1977, The American journal of psychiatry.

[33]  M. Youdim,et al.  EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINE , 1977, British journal of pharmacology.

[34]  J. B. Lassen,et al.  Inhibition of both MAO-A and MAO-B required for the production of hypermotility in mice with the 5HT uptake inhibitors chlorimipramine and femoxetine , 1977, Neuropharmacology.

[35]  F. Sjöqvist,et al.  Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients , 1977, Clinical pharmacology and therapeutics.

[36]  H. Praag.  New Evidence of Serotonin-Deficient Depressions , 1977 .

[37]  A. Carlsson,et al.  Potentiation of the Antidepressant Action of Clomipramine by Tryptophan , 1976 .

[38]  M. Houslay,et al.  Multiple forms of monoamine oxidase: Fact and artefact , 1976 .

[39]  S. Ross,et al.  Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. , 2009, Acta pharmacologica et toxicologica.

[40]  Jacob Cohen,et al.  Applied multiple regression/correlation analysis for the behavioral sciences , 1979 .

[41]  J. Maas.  Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. , 1975, Archives of general psychiatry.

[42]  M. Youdim,et al.  EFFECTS OF MONOAMINE OXIDASE INHIBITION BY CLORGYLINE, DEPRENIL OR TRANYLCYPROMINE ON 5‐HYDROXYTRYPTAMINE CONCENTRATIONS IN RAT BRAIN AND HYPERACTIVITY FOLLOWING SUBSEQUENT TRYPTOPHAN ADMINISTRATION , 1975, British journal of pharmacology.

[43]  J. Vetulani,et al.  Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain , 1975, Nature.

[44]  F. Goodwin,et al.  Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline. , 1975, Archives of general psychiatry.

[45]  F. Goodwin,et al.  Effects of amitriptyline and imipramine on amine metabolites in the cerebrospinal fluid of depressed patients. , 1974, Archives of general psychiatry.

[46]  M. Åsberg,et al.  Indoleamine metabolites in the cerebrospinal fluid of depressed patients before and during treatment with nortriptyline , 1973, Clinical pharmacology and therapeutics.

[47]  G. Heninger,et al.  Cerebrospinal fluid 5-hydroxyindoleactiic acid and homovanillic acid in psychiatric patients. , 1969, International journal of neuropharmacology.

[48]  T. Hökfelt,et al.  Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. , 1969, European journal of pharmacology.

[49]  J. B. Stanton,et al.  5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. , 1966, Lancet.

[50]  David A. Hamburg,et al.  Methods for Reliable Longitudinal Observation of Behavior: Development of a Method for Systematic Observation of Emotional Behavior on Psychiatric Wards , 1963 .

[51]  R. Fisher,et al.  Statistical Methods for Research Workers , 1930, Nature.